-
FDA Commissioner Calls For Sarepta Drug Study To Be Retracted
STAT | The study explored whether the Sarepta drug for Duchenne muscular dystrophy can sufficiently produce higher levels of a protein that provides mobility.
Sep 22, 2016
-
More Doctors To Retire As MACRA And Value-Based Pay Hit
Forbes | Nearly half of U.S. physicians plan to "accelerate" their retirements, cut back on patients or seek "non-clinical roles" as regulations like MACRA take hold, according to The Physicians Foundation.
Sep 21, 2016
-
Mirna Therapeutics Halts Clinical Studies After Patients Get Sick
Austin Business Journal | The company's share price was already down 60% this year before this news on Tuesday caused its stock to fall even further.
Sep 21, 2016
-
Joe Biden: The Next Step in Our Cancer Moonshot
TIME | As part of the Cancer Moonshot, we're announcing new steps to help cancer patients and their doctors find the right clinical trial.
Sep 19, 2016
-
Major Push for Clinical Trial Transparency from HHS, NIH
Clinical Informatics News | The Department of Health and Human Services and the National Institutes of Health announced corresponding efforts on Friday to bring transparency to the clinical trials process. HHS released a final ruling on clinical trials registration and the results information submission process. NIH released a complementary policy on the dissemination of NIH-funded clinical trial information.
Sep 19, 2016
-
Studies Link Cancer Patients Survival Time To Insurance Status
NPR | Research on patients with testicular cancer and on others fighting a brain malignancy finds that people who are privately insured are more likely to be diagnosed earlier and survive longer.
Sep 16, 2016
-
After Setbacks A Pioneering Stem-Cell Technology Is Back in Human Trials
MIT Technology Review | Can cell therapy help spinal-cord injury? A long-running study hopes the answer is yes.
Sep 14, 2016
-
How GlaxoSmithKline Took Its Medicine
Forbes | Andrew Witty inherited a drugmaker sick with scandal and spent the next eight years patching up his patient. GlaxoSmithKline may finally be well again.
Sep 14, 2016
-
Cleveland Clinic Exec: We Need Better Engagement Not More Apps
MobiHealthNews | As the Chief Experience Officer at the Cleveland Clinic, you might expect Adrienne Boissy to be a champion for the health system's many mobile apps. But, at the Pop Health Forum in Chicago this week, Boissy took a different tack, arguing that apps by themselves are not a strategy, and can get in the way of a positive patient experience if they're not deployed smartly.
Sep 14, 2016
-
Should Women Have To Have Counseling Before A BRCA Test?
NPR | Doctors worry that requiring patients to see a separate genetic counselor will keep them from getting tested for mutations that significantly increase the risk of breast and ovarian cancer.
Sep 14, 2016
-
The Struggle To Speed Study Start-up
Clinical Informatics News CROs are looking for new ways to streamline the difficulty of administering clinical trials, focusing most of their efforts on the study start-up phase of a trial.
Sep 13, 2016
-
FDA To Revise Draft Guidance On Quality Metrics Data
RAPS | The FDA has released revisions to the CDER's guidance documents for 2016. Changes in the agency's draft guidance on quality metrics among are notable revisions.
Sep 12, 2016
-
FDA Slams Drug Maker For Touting Unapproved Leukemia Treatment To Docs
STAT | Celator touted its experimental drug for acute myeloid leukemia at a recent cancer conference, but the FDA says the company didn't have clearance to do so.
Sep 8, 2016
-
Birney Takes To Blog To Stress Importance Of Data Sharing
Clinical Informatics | In a recent blog post, Ewan Birney makes a case for why data sharing should extend to the clinical trials community.
Sep 7, 2016
